AstraZeneca PLC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0009895292
GBP
135.14
-2.86 (-2.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
42,316.86
36,853.65
36,005.61
27,508.83
21,518.23
19,113.63
16,566.62
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
42,316.86
36,853.65
36,005.61
27,508.83
21,518.23
19,113.63
16,566.62
Raw Material Cost
10,586.84
9,600.56
13,191.48
10,755.44
5,592.84
5,284.78
4,675.25
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
10,728.49
9,923.16
9,361.25
7,471.08
6,431.14
5,932.25
5,227.22
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,088.58
910.66
721.72
562.78
573.94
605.14
555.72
Selling and Distribution Expenses
12,159.85
11,359.94
10,881.00
8,422.14
7,528.34
7,461.56
6,565.15
Other Expenses
-225.54
-251.16
-225.77
-181.92
-225.29
-236.73
-183.37
Total Expenditure (Excl Depreciation)
32,308.34
29,282.77
31,897.74
25,392.21
17,873.37
16,916.47
15,189.69
Operating Profit (PBDIT) excl Other Income
10008.5
7570.900000000001
4107.900000000001
2116.6
3644.9
2197.2
1376.9
Other Income
363.90
534.97
373.44
1,116.84
343.90
1,184.41
1,593.67
Operating Profit (PBDIT)
14,336.22
12,075.12
8,746.69
6,181.91
6,255.68
5,565.40
5,054.73
Interest
1,088.58
910.66
721.72
562.78
573.94
605.14
555.72
Exceptional Items
-2,460.46
-1,635.49
-1,725.15
-2,782.66
-348.58
-1,475.22
-835.46
Gross Profit (PBDT)
31,730.01
27,253.09
22,814.14
16,753.39
15,925.39
13,828.85
11,891.37
Depreciation
3,963.81
3,969.26
4,265.37
2,982.61
2,258.35
2,180.70
2,084.14
Profit Before Tax
6,823.38
5,559.70
2,034.45
-146.15
3,074.81
1,304.34
1,579.42
Tax
1,291.27
754.59
-642.97
-276.30
602.02
251.62
-42.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,505.50
4,790.63
2,669.31
81.44
2,492.29
1,046.45
1,616.16
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,505.50
4,790.63
2,669.31
81.44
2,492.29
1,046.45
1,616.16
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.70
4.83
4.06
2.18
-40.55
-84.66
-78.75
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,510.20
4,795.46
2,673.37
83.62
2,451.74
961.80
1,537.42
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.2
0.2
0.21
0.18
0.18
0.19
0.2
Reserves
32,566.27
30,705.21
30,789.76
28,991.84
11,428.36
9,909.04
9,789.57
Earnings per share (EPS)
3.52
3.07
1.71
0.06
1.9
0.8
1.28
Diluted Earnings per share
3.52
3.07
1.71
0.06
1.9
0.8
1.28
Operating Profit Margin (Excl OI)
23.65%
20.54%
11.41%
7.57%
16.98%
11.51%
8.31%
Gross Profit Margin
25.49%
25.86%
17.5%
10.31%
24.78%
18.23%
22.11%
PAT Margin
13.01%
13.0%
7.41%
0.3%
11.58%
5.47%
9.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 14.82% vs 2.36% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 14.90% vs 79.38% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 21.08% vs 37.82% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 19.53% vs 26.19% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of AstraZeneca PLC With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(GBP)
Change(%)
Net Sales
42,316.86
31,376.00
10,940.86
34.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
42,316.86
31,376.00
10,940.86
34.87%
Raw Material Cost
10,586.84
9,476.00
1,110.84
11.72%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
10,728.49
8,327.00
2,401.49
28.84%
Power Cost
0
0
0.00
Manufacturing Expenses
1,088.58
644.00
444.58
69.03%
Selling and Distribution Expenses
12,159.85
10,741.00
1,418.85
13.21%
Other Expenses
-225.54
-347.40
121.86
35.08%
Total Expenditure (Excl Depreciation)
32,308.34
25,714.00
6,594.34
25.64%
Operating Profit (PBDIT) excl Other Income
10,008.51
5,662.00
4,346.51
76.77%
Other Income
363.90
931.00
-567.10
-60.91%
Operating Profit (PBDIT)
14,336.22
9,144.00
5,192.22
56.78%
Interest
1,088.58
644.00
444.58
69.03%
Exceptional Items
-2,460.46
-2,469.00
8.54
0.35%
Gross Profit (PBDT)
31,730.01
21,900.00
9,830.01
44.89%
Depreciation
3,963.81
2,551.00
1,412.81
55.38%
Profit Before Tax
6,823.38
3,480.00
3,343.38
96.07%
Tax
1,291.27
526.00
765.27
145.49%
Provisions and contingencies
0
0
0.00
Profit After Tax
5,505.50
2,575.00
2,930.50
113.81%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
5,505.50
2,575.00
2,930.50
113.81%
Share in Profit of Associates
0
0
0.00
Minority Interest
4.70
376.00
-371.30
-98.75%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,510.20
2,951.00
2,559.20
86.72%
Equity Capital
0
0
0.00
Face Value
0.20
0.31
0.00
Reserves
32,566.27
13,671.00
18,895.27
138.21%
Earnings per share (EPS)
3.52
0.62
2.90
467.74%
Diluted Earnings per share
3.52
0.62
2.90
467.74%
Operating Profit Margin (Excl OI)
23.65%
18.05%
0.00
5.60%
Gross Profit Margin
25.49%
19.22%
0.00
6.27%
PAT Margin
13.01%
8.21%
0.00
4.80%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 4,231.69 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 14.82% vs 2.36% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 551.02 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 14.90% vs 79.38% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,397.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.08% vs 37.82% in Dec 2023

Annual - Interest
Interest 108.86 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 19.53% vs 26.19% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.65%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023